Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Time-restricted Eating in Patients With Metabolic-associated Steatotic Liver Disease . CHRONOMASLD: A Chrononutrition/Chronotoxicity Randomized Controlled Trial.

NCT06705868 is registered in ClinicalTrials.gov with Cyprus University of Technology as lead sponsor.

NCT NCT06705868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06705868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Time-restricted Eating in Patients With Metabolic-associated Steatotic Liver Disease . CHRONOMASLD: A Chrononutrition/Chronotoxicity Randomized Controlled Trial.
Lead sponsor
Cyprus University of Technology
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 5, 2026
Completion date
December 15, 2029
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

masld, masld - metabolic dysfunction-associated steatotic liver disease, nafld, nafld (nonalcoholic fatty liver disease), nafld - non-alcoholic fatty liver disease